Dawnrays Pharmaceutical (Holdings) Limited
Dawnrays Pharmaceutical (Holdings) Limited (HKSE: 2348) is trading at HK$0.98, about ₹12 at today's HKD/INR rate, as of 30 Sep 2026, 2:38 AM ET, down 0.51% today. Indian residents can buy Dawnrays Pharmaceutical (Holdings) from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$0.97
Today's high
HK$0.98
52 week low
HK$0.97
52 week high
HK$1.26
2348 opened at HK$0.97, closed previously at HK$0.98, and has traded between HK$0.97 and HK$1.26 over the past 52 weeks.
About
Dawnrays Pharmaceutical (Holdings) Limited operates as an investment holding company, primarily engaged in the creation, production, and global distribution of generic pharmaceutical medicines, with a focus on Mainland China and international markets. Its operations are divided into two main divisions: Intermediates and Bulk Medicines, and Finished Drugs. The company's diverse product portfolio features a range of antibiotics, including pharmaceutical intermediates, bulk active ingredients, powdered formulations for injection, and oral antibiotic preparations. Furthermore, Dawnrays offers specialized medications addressing various bodily systems and conditions, such as those for cardiovascular health, allergies, Hepatitis B Virus (HBV), digestive and urinary issues, antipyretic-analgesic (fever and pain relief), respiratory ailments, and endocrine disorders. These system-specific drugs are dispensed in familiar forms like tablets, capsules, and granules. Founded in 1995, the firm maintains its headquarters in Wan Chai, Hong Kong, and is a subsidiary of Fortune United Group Limited.
Key statistics
Avg. volume
135.29K
Market cap
HK$1.47B
P/E Ratio
5.46
Price-to-sales ratio
1.10
Enterprise value
CN¥558.46M
Free cash flow yield
14.32%
Debt-to-equity ratio
0.00
Return on equity
6.32%
ROIC
5.40%
Beta
0.23
Dividend yield
6.46%
Last dividend
HK$0.06
Financial overview
Revenue
CN¥1.23B
Earnings per share
CN¥0.14
Free cash flow
CN¥236.01M
Net profit margin
20.29%
Gross margin
47.81%
EBITDA
CN¥343.66M
Revenue growth
16.09%
Similar securities
This is not an investment recommendation
How to buy Dawnrays Pharmaceutical (Holdings) from India
Indian residents can buy Dawnrays Pharmaceutical (Holdings) shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Dawnrays Pharmaceutical (Holdings) and place an order
Find Dawnrays Pharmaceutical (Holdings) by name or by its ticker, 2348, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Dawnrays Pharmaceutical (Holdings) trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Dawnrays Pharmaceutical (Holdings) position in HKD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Dawnrays Pharmaceutical (Holdings) from India
Trading and taxes when buying Dawnrays Pharmaceutical (Holdings) from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Dawnrays Pharmaceutical (Holdings)’s current yield is 6.46%.Dividend tax explained
- Estate or inheritance tax
- May applyHong Kong has no estate duty.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Dawnrays Pharmaceutical (Holdings) stock?
Yes. Dawnrays Pharmaceutical (Holdings) (2348) has been listed on the Hong Kong Stock Exchange since 2003, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Dawnrays Pharmaceutical (Holdings) share cost in rupees?
One Dawnrays Pharmaceutical (Holdings) share is HK$0.98 — about ₹12 at an HKD/INR rate of 12.24 on 29 Sep 2026. Both the Dawnrays Pharmaceutical (Holdings) price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Dawnrays Pharmaceutical (Holdings) from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Dawnrays Pharmaceutical (Holdings)?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Dawnrays Pharmaceutical (Holdings) shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Dawnrays Pharmaceutical (Holdings) price. Paasa issues a capital-gains statement for your return.
Does Dawnrays Pharmaceutical (Holdings) pay a dividend, and how is it taxed in India?
Yes. Dawnrays Pharmaceutical (Holdings) pays a dividend and the current yield is 6.46%; the last declared dividend was HK$0.06 per share, about ₹0.77. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Dawnrays Pharmaceutical (Holdings) from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on Dawnrays Pharmaceutical (Holdings) shares held from India?
Hong Kong has no estate duty.
Do I have to declare Dawnrays Pharmaceutical (Holdings) shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Dawnrays Pharmaceutical (Holdings) holding, its cost and its closing value.
How do I sell Dawnrays Pharmaceutical (Holdings) and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.